Pacira BioSciences, Inc. PCRX Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s other income, net (note 6)?
- Pacira BioSciences, Inc. (PCRX) reported other income, net (note 6) of -$135K in Q1 2026.
- How has Pacira BioSciences, Inc.'s other income, net (note 6) changed year-over-year?
- Pacira BioSciences, Inc.'s other income, net (note 6) decreased by 103.1% year-over-year, from $4.4M to -$135K.
- What is the long-term trend for Pacira BioSciences, Inc.'s other income, net (note 6)?
- Over 3 years (2021 to 2025), Pacira BioSciences, Inc.'s other income, net (note 6) has grown at a 35.4% compound annual growth rate (CAGR), from -$2.67M to -$6.62M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.